| |
Latest 10 SEC filings (by transaction date) for ANAB within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 26/24 | Mar 26/24 | Faga Daniel | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -347,441 | $21.60 |
Mar 26/24 | Mar 25/24 | Faga Daniel | Direct Ownership | Common Stock | S - Open market or private sale | -3,000 | $21.42 |
Mar 26/24 | Mar 22/24 | Faga Daniel | Direct Ownership | Common Stock | S - Open market or private sale | -145,940 | $22.78 |
Feb 21/24 | Feb 16/24 | Loumeau Eric J | Direct Ownership | Employee Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Feb 21/24 | Feb 16/24 | Loumeau Eric J | Direct Ownership | Common Stock | S - Open market or private sale | -5,000 | $25.00 |
Feb 21/24 | Feb 16/24 | Loumeau Eric J | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,000 | $14.02 |
Feb 1/24 | Jan 30/24 | Mulroy Dennis | Direct Ownership | Common Stock | S - Open market or private sale | -3,065 | $23.63 |
Jan 9/24 | Jan 8/24 | Lizzul Paul F. | Direct Ownership | Common Stock | S - Open market or private sale | -2,554 | $21.81 |
Jan 9/24 | Jan 8/24 | Loumeau Eric J | Direct Ownership | Common Stock | S - Open market or private sale | -2,305 | $21.81 |
Jan 9/24 | Jan 8/24 | Mulroy Dennis | Direct Ownership | Common Stock | S - Open market or private sale | -2,180 | $21.81 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ANAB within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 26/24 | Mar 26/24 | Faga Daniel | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -347,441 | $21.60 |
Mar 26/24 | Mar 25/24 | Faga Daniel | Direct Ownership | Common Stock | S - Open market or private sale | -3,000 | $21.42 |
Mar 26/24 | Mar 22/24 | Faga Daniel | Direct Ownership | Common Stock | S - Open market or private sale | -145,940 | $22.78 |
Feb 21/24 | Feb 16/24 | Loumeau Eric J | Direct Ownership | Employee Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Feb 21/24 | Feb 16/24 | Loumeau Eric J | Direct Ownership | Common Stock | S - Open market or private sale | -5,000 | $25.00 |
Feb 21/24 | Feb 16/24 | Loumeau Eric J | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,000 | $14.02 |
Feb 1/24 | Jan 30/24 | Mulroy Dennis | Direct Ownership | Common Stock | S - Open market or private sale | -3,065 | $23.63 |
Jan 9/24 | Jan 6/24 | Lizzul Paul F. | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -6,145 | |
Jan 9/24 | Jan 8/24 | Lizzul Paul F. | Direct Ownership | Common Stock | S - Open market or private sale | -2,554 | $21.81 |
Jan 9/24 | Jan 6/24 | Lizzul Paul F. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 6,145 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |